Showing results (111-120 of 147) with videos related to
Sort By:
Pageof 15
Journal of Enzyme Inhibition and Medicinal Chemistry|January 12, 2023
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agentsMohammad M Al-Sanea, Abdelrahman Hamdi, Simone Brogi, et al.ACS Infectious Diseases|July 26, 2022
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery ApproachTheo Battista, Stefano Federico, Simone Brogi, et al.Molecules (Basel, Switzerland)|November 17, 2020
Cinnamides Target <i>Leishmania amazonensis</i> Arginase SelectivelyEdson Roberto da Silva, Júlio Abel Alfredo Dos Santos Simone Come, Simone Brogi, et al.Journal of Biomolecular Structure & Dynamics|August 31, 2021
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike proteinRey Arturo Fernandez, Mark Tristan Quimque, Kin Israel Notarte, et al.Oxidative Medicine and Cellular Longevity|February 13, 2020
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1Lara Testai, Eugenia Piragine, Ilaria Piano, et al.European Journal of Medicinal Chemistry|November 17, 2020
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, A Prasanth Saraswati, Giulia Chemi, et al.Apoptosis : an International Journal on Programmed Cell Death|July 4, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4Vanessa Tatangelo, Gabriele Carullo, Ludovica Lopresti, et al.Chemmedchem|August 8, 2018
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic PainMargherita Brindisi, Giuseppe Borrelli, Simone Brogi, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 5, 2024
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Vanessa Tatangelo, Maria Dichiara, et al.European Journal of Medicinal Chemistry|August 6, 2022
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant propertiesMario Saletti, Samuele Maramai, Annalisa Reale, et al.Pageof 15